Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Angiolink Corporation
company
About
Angiolink privately held medical device company focused on developing innovative wound closure solutions for vascular procedures.
- 11 - 50
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $10.60M
- Industries
- Biotechnology,Health Care,Innovation Management,Medical,Medical Device
- Founded date
- Jan 1, 1999
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Angiolink Corporation offers EVS vascular closure system, an arterial stapling device for use in closing holes and punctures made in arteries in connection with the catheter-based surgical procedures, such as angioplasty and angiograms.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$24.20M
Angiolink Corporation has raised a total of
$24.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 10, 2003 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 10, 2003 | Series B | $13.60M | 1 | — | — | Detail |
| Sep 17, 2002 | Series A | $10.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Angiolink Corporation is funded by 1 investors.
Boston Financial & Equity Corporation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Boston Financial & Equity Corporation
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
